4//SEC Filing
Oh Jeong Gyun 4
Accession 0001683168-20-000015
CIK 0001638287other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:53 PM ET
Size
8.2 KB
Accession
0001683168-20-000015
Insider Transaction Report
Form 4
Oh Jeong Gyun
Director10% Owner
Transactions
- Award
Common Stock
2019-12-30+240,051→ 240,051 total(indirect: By Spouse) - Award
Common Stock
2019-12-30+1,817,842→ 1,817,842 total(indirect: Held by JK BioPharma Solutions, Inc.)
Footnotes (5)
- [F1]Received in connection with the closing of the merger of GR Merger Sub Inc., a wholly-owned subsidiary of the Issuer, with and into NeuroBo Therapeutics, Inc. (formerly NeuroBo Pharmaceuticals, Inc.) ("NeuroBo") on December 30, 2019, in exchange for (i) 1,000,000 shares of common stock of NeuroBo and (ii) 590,274 shares of common stock of NeuroBo issued upon conversion of convertible promissory notes of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by JK BioPharma Solutions, Inc.
- [F2]Mr. Oh is the President and Chief Executive Officer of JK BioPharma Solutions, Inc., and as such has voting and investment control over the shares held by JK BioPharma Solutions, Inc.
- [F3]Received in connection with the closing of the Merger in exchange for 210,000 shares of common stock of NeuroBo issued upon the conversion of Series B preferred stock of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by the spouse of Jeong Gyun Oh.
- [F4]In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock.
- [F5]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001794777
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 9:53 PM ET
- Size
- 8.2 KB